What is the CVSS score of CVE-2023-32662?

CVE-2023-32662 has a CVSS 3.1 base score of 6.7 (Medium). CVSS vector: CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H. EPSS exploitation probability: 0.2%.

Battery Life Diagnostic Tool CVE-2023-32662

MEDIUM

Improper Authorization (CWE-285)

2023-11-14 secure@intel.com

Privilege Escalation Intel Authentication Bypass Battery Life Diagnostic Tool

6.7

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

6.7 MEDIUM

AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H

Attack Vector

Local

Attack Complexity

Low

Privileges Required

High

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

High

Availability

High

Lifecycle Timeline

CVE Published

Nov 14, 2023 - 19:15 nvd

MEDIUM 6.7

DescriptionNVD

AnalysisAI

Improper authorization in some Intel Battery Life Diagnostic Tool installation software before version 2.2.1 may allow a privilaged user to potentially enable escalation of privilege via local access. Rated medium severity (CVSS 6.7), this vulnerability is low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified under CWE-285. Improper authorization in some Intel Battery Life Diagnostic Tool installation software before version 2.2.1 may allow a privilaged user to potentially enable escalation of privilege via local access. Affected products include: Intel Battery Life Diagnostic Tool. Version information: version 2.2.1.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.